HPS0775-95
166603-46-9
默认>95%HPLC，若需其他规格请洽询
| 产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
|---|---|---|---|---|---|---|
| HPS0775-95 | 默认>95%HPLC，若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
 
|
| 名字 | Human CMV Assemblin Protease Inhibitor |
|---|---|
| 序列(三字母) | H-Arg-Gly-Val-Val-Asn-Ala-psi(CH₂NH)Ser-Ser-Arg-Leu-Ala-OH |
| 序列(单字母) | RGVVNA-psi(CH₂NH)-SSRLA |
| CAS# | 166603-46-9 |
| 分子式 | C₄₆H₈₆N₁₈O₁₄ |
| 分子量 | 1115.3 |
| 纯度 | 默认>95%HPLC，若需其他规格请洽询 |
| 合成方法 | Synthetic |
| 储存条件 | -20 ± 5 °C |
| 应用 | Virology |
| 描述 | This inhibitor of the human CMV assemblin protease is derived from RGVVNASSRLAK, the M-site substrate of the protease. RGVVNA-psi[CH2-NH]SSRLA contains a non-hydrolyzable reduced peptide bond at the cleavage site. Its IC₅₀ value is high (> 500 µM) but it is the first peptidomimetic inhibitor designed for the human CMV protease. |
